story of the week
Safety and Efficacy of Teriflunomide in Pediatric Multiple Sclerosis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Neurology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Safety and efficacy of teriflunomide in paediatric multiple sclerosis (TERIKIDS): a multicentre, double-blind, phase 3, randomised, placebo-controlled trial
Lancet Neurol 2021 Dec 01;20(12)1001-1011, T Chitnis, B Banwell, L Kappos, DL Arnold, K Gücüyener, K Deiva, N Skripchenko, LY Cui, S Saubadu, W Hu, M Benamor, A Le-Halpere, P Truffinet, M TardieuFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.